Chairperson(s) : Hee-Yeol Kim (Incheon Sejong Hospital, Republic of Korea), Myung-gon Kim (Catholic Kwandong University, Republic of Korea)
Chairperson(s) : Jae Hyoung Park (Korea University, Republic of Korea)
Chairperson(s) : Jeong-Taek Woo (Kyung Hee University, Republic of Korea)
Chairperson(s) : Byung Ryul Cho (Kangwon National University, Republic of Korea), Bong-Ki Lee (Kangwon National University, Republic of Korea)
Chairperson(s) : Jung-Kyu Han (Seoul National University, Republic of Korea), Cheol-Ung Choi (Korea University, Republic of Korea)
-
[OP2-1] Renal lipidomic profiling reveals boerhaavia diffusa extract ameliorates saturated fatty acid lipotoxicity and mitochondrial decay independent of systemic adiposity
Lee On Ying The Hong Kong Polytechnic University, China 08:30~08:40 -
[OP2-2] Extrahepatic bile acid synthesis reprograms multiorgan cholesterol flux in cardiovascular disease
Hosung Bae University of Iowa, United States 08:40~08:50 -
[OP2-3] Prdx3 deficiency triggers cGAS-STING signaling pathway induced vascular smooth muscle cell senescence and phenotypic switching in abdominal aortic aneurysm
Moajury Jung Ewha Womans University, Republic of Korea 08:50~09:00 -
[OP2-4] Sphingosine-1-phosphate receptor 1 deletion in smooth muscle cells protects against atherosclerosis in apoE-deficient mice by reducing lipid droplet formation
Bernardo Trigatti Hamilton Health Sciences, Canada 09:00~09:10 -
[OP2-5] Senolytic therapy attenuates atherosclerosis and metabolic dysfunction by targeting cellular senescence in western diet-fed Ldlr KO mice
Hye Rang Park Korea Research Institute of Bioscience and Biotechnology (KRIBB), Republic of Korea 09:10~09:20 -
[OP2-6] The role of LGI3 in adipocytes and macrophages in atherosclerosis
Do Hee Yu Department of Life Sciences, Ewha Womans University, Republic of Korea 09:20~09:30 -
[OP2-7] Cyclic induction of OSKM expression mitigates atherosclerosis through vascular anti-inflammatory remodeling independent of systemic metabolic effects
Young Hoon Seo Korea Research Institute of Bioscience and Biotechnology (KRIBB), Republic of Korea 09:30~09:40 -
[OP2-8] Extracellular vesicles produced by M2-polarized macrophages drive atherosclerosis regression by reprograming Ly-6Chi monocytes & enhancing efferocytosis
Robert L. Raffai University of California, San Francisco, United States 09:40~09:50
Chairperson(s) : Sungha Park (Yonsei University, Republic of Korea), Sang-Hak Lee (Yonsei University, Republic of Korea)
Panel(s) : Gyu Chul Oh (The Catholic University of Korea, Republic of Korea), Ji-Yong Jang (National Health Insurance Service Ilsan Hospital, Republic of Korea), Yun Kyung Cho (University of Ulsan, Republic of Korea)
-
Bempedoic acid: LDL-C lowering beyond statins - evidence and clinical role
Chewan Lim Catholic Kwandong University, Republic of Korea 08:30~08:50 -
Optimizing non-statin therapy: PCSK9 inhibitors and inclisiran
Kyung-Hee Kim Incheon Sejong Hospital, Republic of Korea 08:50~09:10 -
Emerging Lp(a)-lowering therapies: siRNA, ASO, and beyond
Yu-Chen Wang Asia University, Taiwan 09:10~09:30 - Panel Discussion 09:30~10:00
Chairperson(s) : Jung-Sun Kim (Yonsei University, Republic of Korea), Junghyun Noh (Inje University, Republic of Korea)
Panel(s) : Sang Yong Kim (Chosun University, Republic of Korea), Ji Woong Yoo (Hallym University, Republic of Korea), Mi-Hyang Jung (The Catholic University of Korea, Republic of Korea)
-
Lipid-lowering therapy in people living with HIV (PLWH)
So Ree Kim Korea University, Republic of Korea 08:30~08:48 -
Lipid-lowering therapy in cancer patients and survivors
Hiroshi Akazawa Kanazawa Medical University, Japan 08:48~09:06 -
Lipid-lowering therapy in patients with CKD
Eun Sil Koh The Catholic University of Korea, Republic of Korea 09:06~09:24 -
Cardiovascular prevention in hemodialysis: is omega-3 back?
Sang Ho Jo Hallym University, Republic of Korea 09:24~09:42 - Panel Discussion 09:42~10:00
Chairperson(s) : Yong Sook Kim (Chonnam National University, Republic of Korea), Hyeong-Gyu Kim (Inje University, Republic of Korea)
Panel(s) : Nari Kim (Inje University, Republic of Korea), Jong-Gil Park (Korea Research Institute of Bioscience and Biotechnology, Republic of Korea), Dong Kyu Choi (Kyungpook National University, Republic of Korea)
-
Ion channels in atherosclerosis: from calcium flux to vascular dysfunction
Sung Joon Kim Seoul National University, Republic of Korea 08:30~08:50 -
Energy metabolism and lipid oxidation in cardiometabolic pathophysiology
Jin Han Inje University, Republic of Korea 08:50~09:10 -
Lp(a): from lipoprotein biology to atherosclerotic cardiovascular disease
Jung-Woo Son Yonsei University, Republic of Korea 09:10~09:30 - Panel Discussion 09:30~10:00
Chairperson(s) : Sung Rae Kim (The Catholic University of Korea, Republic of Korea)
Chairperson(s) : TBD (Affiliation, Country)
Chairperson(s) : Young-Bae Park (Seoul National University, Republic of Korea)
-
Start early: upfront combination therapy for faster LDL-C goal attainment in the CKM era
Soo-Jin Kim Kosin University, Republic of Korea 11:45~12:00 -
Start strong: elevating LDL-C management in ASCVD with high-dose atorvastatin plus ezetimibe
Jeehoon Kang Seoul National University, Republic of Korea 12:00~12:15
Chairperson(s) : Kyong Soo Park (Konkuk University, Republic of Korea), Myung A Kim (Seoul National University, Republic of Korea)
Chairperson(s) : Hyo-Soo Kim (Seoul National University, Republic of Korea)
Chairperson(s) : Moon-Kyu Lee (Eulji University, Republic of Korea)
Chairperson(s) : Hyun Ho Shin (Asan Chungmu Hospital, Republic of Korea)
Chairperson(s) : Sung Rae Kim (The Catholic University of Korea, Republic of Korea), Sang-Hyun Kim (Seoul National University, Republic of Korea)
- 2026 KSoLA Award Ceremony for Scientific Excellence & Young Investigator 12:45~12:50
-
The quiet signal, no longer - triglyceride at the crossroads of insulin resistance and cardiometabolic risk
Cheol-Young Park Sungkyunkwan University, Republic of Korea 12:50~13:10 - Q&A 13:10~13:15
-
The health information on social media: the reliability and professionals’ responsibility
Il Hak Lee Yonsei University, Republic of Korea 13:15~13:35 - Q&A 13:35~13:40
Chairperson(s) : Mi-Seung Shin (Gachon University, Republic of Korea), Jun-Hee Lee (Hallym University, Republic of Korea)
Panel(s) : Hack-Lyoung Kim (Seoul National University, Republic of Korea), Ye Seul Yang (Seoul National University, Republic of Korea), Seok Oh (Chonnam National University, Republic of Korea)
-
Sex differences in lipids and lipoproteins and residual cardiovascular risk: beyond LDL cholesterol
Soo-Jin Kim Kosin University, Republic of Korea 12:45~13:00 -
Early-onset dyslipidemia in young adults: screening strategies and lifetime ASCVD risk assessment
Jaehyun Bae Hallym University, Republic of Korea 13:00~13:15 -
Menopause and cardiometabolic transition: optimizing lipid management in midlife women
In Jeong Cho Ewha Womans University, Republic of Korea 13:15~13:30 - Panel Discussion 13:30~13:45
Chairperson(s) : Sang-Hyun Kim (Seoul National University, Republic of Korea), Woo Je Lee (University of Ulsan, Republic of Korea)
Panel(s) : Eunju Park (Kyungnam University, Republic of Korea), Jee Hee Yoo (Chung-Ang University, Republic of Korea), Hye Moon Chung (Kyung Hee University, Republic of Korea)
-
Korean epidemiology and risk modifiers for establishing LDL-C goal strategies
Jong Han Choi Konkuk University, Republic of Korea 13:45~14:03 -
Practical algorithm for intensive lipid lowering therapy in the 2026 Korean guidelines
Jaehoon Chung Gachon University, Republic of Korea 14:03~14:21 -
Nutritional management and lifestyle modification tailored to the Korean dietary pattern
Garam Jo Hannam University, Republic of Korea 14:21~14:39 -
Optimized lipid management for special populations
Byung Sik Kim Hanyang University, Republic of Korea 14:39~14:57 - Panel Discussion 14:57~15:15
Chairperson(s) : Donghoon Choi (Yonsei University, Republic of Korea), Kyung Woo Park (Seoul National University, Republic of Korea)
Panel(s) : Jaehyun Bae (Hallym University, Republic of Korea), Heung Yong Jin (Jeonbuk National University, Republic of Korea), Jung-Kyu Han (Seoul National University, Republic of Korea)
-
Lipoprotein(a) in Korean patients: real-world data, cardiovascular risk, and clinical implications
Sang Min Park Eulji University, Republic of Korea 13:45~14:05 -
Lipoprotein(a) and coronary atherosclerosis in Vietnam: real-world data and emerging cardiovascular risk
Anh Tien Hoang Hue University, Vietnam 14:05~14:25 -
Measuring Lipoprotein(a) in clinical practice: assay challenges, standardization, and interpretation
Sang-Guk Lee Yonsei University, Republic of Korea 14:25~14:45 - Panel Discussion 14:45~15:15
Chairperson(s) : Jung Rae Cho (Hallym University, Republic of Korea), Byung Jin Kim (Sungkyunkwan University, Republic of Korea)
Panel(s) : Bom Lee (CHA University, Republic of Korea), Hyun Sung Joh (Seoul National University, Republic of Korea), Hyung Joon Joo (Korea University, Republic of Korea)
-
Evolution of vulnerable plaques: from natural history to preventive intervention
Jin Ho Lee Kyung Hee University, Republic of Korea 13:45~14:03 -
High-risk plaque features on CCTA: identification and clinical implications
Sang Yoon Lee Sungkyunkwan University, Republic of Korea 14:03~14:21 -
Intravascular imaging of vulnerable plaques: insights from IVUS and OCT
Ju Hyeon Kim University of Ulsan, Republic of Korea 14:21~14:39 -
Coronary physiology and plaque vulnerability: integrative relationship and prognostic implications
Seok Hun Yang Seoul National University, Republic of Korea 14:39~14:57 - Panel Discussion 14:57~15:15
Chairperson(s) : Seok-Min Kang (Yonsei University, Republic of Korea), Ki Chul Sung (Sungkyunkwan University, Republic of Korea)
Panel(s) : Bo Kyung Koo (Seoul National University, Republic of Korea), Kyung-Jin Kim (Ewha Womans University, Republic of Korea), Heesun Lee (Seoul National University, Republic of Korea)
-
Fatty liver and residual cardiovascular risk: epidemiology and clinical implications
Eun Jung Rhee Sungkyunkwan University, Republic of Korea 13:45~14:05 -
From lipotoxicity to atherosclerosis: MASLD/MetALD subtypes and cardiovascular risk - a hepatologist’s perspective
Su Jong Yu Seoul National University, Republic of Korea 14:05~14:25 -
Therapeutic strategies for cardiometabolic risk reduction in MASLD
Toru Miyoshi Okayama University, Japan 14:25~14:45 - Panel Discussion 14:45~15:15
Chairperson(s) : Woo Je Lee (University of Ulsan, Republic of Korea)
Chairperson(s) : Sang-Hyun Lim (The Catholic University of Korea, Republic of Korea), Eung Gyu Kim (Inje University, Republic of Korea)
Panel(s) : Hyung-Min Kwon (Seoul National University, Republic of Korea), Minjeong Kim (Ewha Womans University, Republic of Korea), Garam Cho (Hannam University, Republic of Korea)
-
PCSK9 inhibition in primary prevention: insights from VESALIUS-CV and clinical implications
Doo Sun Sim Chonnam National University, Republic of Korea 16:10~16:30 -
Low LDL-C and brain safety: risk of hemorrhagic stroke and cognitive dysfunction
Kwang-Yeol Park Chung-Ang University, Republic of Korea 16:30~16:50 -
Early combination therapy in primary prevention
Hoyoun Won Chung-Ang University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : Sang Yup Lim (Korea University, Republic of Korea)
Panel(s) : Byung Sik Kim (Hanyang University, Republic of Korea), Eun Jung Rhee (Sungkyunkwan University, Republic of Korea), Jang Hoon Lee (Kyungpook National University, Republic of Korea)
-
CETP inhibition revisited: obicetrapib for LDL-C reduction and ASCVD risk management
Mariko Harada-Shiba Osaka Medical and Pharmaceutical University, Japan 16:10~16:30 -
APOC3 inhibition: targeting triglyceride-rich lipoproteins and residual risk
Jin Wi Gachon University, Republic of Korea 16:30~16:50 -
ANGPTL3 inhibition: expanding therapeutic opportunities beyond LDL-C
Hye Moon Chung Kyung Hee University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : Seung Woo Park (Sungkyunkwan University, Republic of Korea), Young-Hoon Jeong (Chung-Ang University, Republic of Korea)
Panel(s) : Jaehyun Bae (Hallym University, Republic of Korea), Jung Myung Lee (Sahmyook Medical Center, Republic of Korea), Jong Han Choi (Konkuk University, Republic of Korea), Jong Han Choi (Konkuk University, Republic of Korea)
-
Defining residual cardiovascular risk in the post-LDL era: unmet needs and mechanisms
Hyung Joon Joo Korea University, Republic of Korea 16:10~16:30 -
Targeting residual risk: Lp(a), triglyceride-rich lipoproteins, and inflammation
Sung Gyun Ahn Yonsei University, Republic of Korea 16:30~16:50 -
Beyond less is more: navigating residual thrombotic and inflammatory risk in AF and stable CAD
Satoshi Yasuda Tohoku University, Japan 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : Min Sun Kim (University of Ulsan, Republic of Korea), In-Kyung Jeong (Kyung Hee University, Republic of Korea)
Panel(s) : Song-Yi Kim (Jeju National University, Republic of Korea), Jee Hee Yoo (Chung-Ang University, Republic of Korea), Heung Yong Jin (Jeonbuk National University, Republic of Korea)
-
Lipid remodeling of adipose tissue: the hidden link between obesity and atherosclerosis
Yun-Hee Lee Seoul National University, Republic of Korea 16:10~16:30 -
Remnant cholesterol and residual cardiovascular risk in obesity
Young-Sang Lyu Chosun University, Republic of Korea 16:30~16:50 -
Dual targeting of lipid and weight: emerging therapies and clinical strategies
Chang Hee Jung University of Ulsan, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
